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Linear and logistic regression analyses were performed 
adjusting for relevant environmental and biological fac-
tors. The pattern of SNP associations was distinct between 
AAs and EAs. In AAs, six GWAS-identified SNPs in GC, 
CYP2R1, and DHCR7/NADSYN1 were replicated, while 
nine GWAS SNPs in GC and CYP2R1 were replicated in 
EAs. A CYP2R1 SNP, rs12794714, exhibited the strong-
est signal of association in AAs. In EAs, however, a dif-
ferent CYP2R1 SNP, rs1993116, was the most strongly 
associated. Our models, which take into account genetic 
and environmental variables, accounted for 20 and 28 % of 
the variance in serum vitamin D levels in AAs and EAs, 
respectively.
Abstract Vitamin D deficiency is more common among 
African Americans (AAs) than among European Ameri-
cans (EAs), and epidemiologic evidence links vitamin D 
status to many health outcomes. Two genome-wide asso-
ciation studies (GWAS) in European populations identified 
vitamin D pathway gene single-nucleotide polymorphisms 
(SNPs) associated with serum vitamin D [25(OH)D] levels, 
but a few of these SNPs have been replicated in AAs. Here, 
we investigated the associations of 39 SNPs in vitamin D 
pathway genes, including 19 GWAS-identified SNPs, with 
serum 25(OH)D concentrations in 652 AAs and 405 EAs. 
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Introduction
Many chronic diseases are disproportionately distributed 
in the US populations. Diabetes mellitus, cardiovascu-
lar diseases, several malignancies, and other diseases are 
more prevalent among African Americans (AAs) relative 
to European Americans (EAs) and Asian Americans. Dif-
ferences in serum vitamin D [25(OH)D] concentration 
among racial/ethnic groups are suspected to be one of the 
sources of health disparities (Grant and Peiris 2010; Harris 
2011). Numerous studies demonstrated that AAs have sig-
nificantly lower serum 25(OH)D levels than EAs (Benja-
min et al. 2009; Chan et al. 2010; Ginde et al. 2009; Harris 
et al. 2000; Looker et al. 2008; Murphy et al. 2012; Nesby-
O’Dell et al. 2002; Shea et al. 2011; Tseng et al. 2009). 
Vitamin D deficiency is common even among AAs who live 
in sunlight intense southern and southwestern states or who 
have higher dietary vitamin D intake than the longstanding 
recommended daily allowance (≥400 IU/day) (Egan et al. 
2008; Jacobs et al. 2008; Tseng et al. 2009). Although the 
causal mechanism involved in risk is unknown, there is also 
epidemiologic evidence linking vitamin D status to several 
types of cancer (e.g., breast, colon, and prostate cancer), 
bone diseases (e.g., rickets, osteomalacia, and osteoporo-
sis), cardiovascular diseases, diabetes, autoimmune dis-
eases, microbial infections, childhood asthma and allergy, 
and other health conditions (Grant and Peiris 2010, 2012; 
Hossein-nezhad and Holick 2013; Litonjua 2012). High 
disease burden in AAs could be due to the contrasting 
effects of dark skin pigmentation which evolved in their 
ancestral African environment and low ultraviolet radiation 
(UVR) in their new environment (Jablonski and Chaplin 
2012).
Circulating levels of 25(OH)D are strongly influenced 
by multiple factors. Various studies have demonstrated that 
dietary intake, dietary supplement use, season of blood 
draw, UVR exposure, smoking, sex, age, body mass index 
(BMI), and race/ethnicity are important predictors of serum 
25(OH)D levels (Chan et al. 2010; Egan et al. 2008; Mur-
phy et al. 2012; Shea et al. 2011). Of these predictors, 
many studies repeatedly demonstrated the strong associa-
tions of vitamin D intake and season of blood draw with 
serum 25(OH)D levels.
Genetic epidemiological studies also identified vari-
ants that were associated with serum 25(OH)D levels. Two 
meta-analyses of genome-wide association studies (GWAS) 
in European descent populations found single-nucleotide 
polymorphisms (SNPs) in vitamin D pathway genes associ-
ated with serum 25(OH)D levels (Ahn et al. 2010; Wang 
et al. 2010). In these GWAS meta-analyses, the strongest 
signals of association were observed in GC (vitamin D 
binding protein), DHCR7 (7-dehydrocholesterol reductase) 
and NADSYN1 region, and CYP2R1 (cytochrome P450, 
family 2, subfamily R, polypeptide 1). Smaller scale rep-
lication and candidate gene studies in European and Asian 
populations also demonstrated the association of variants in 
these gene regions with serum 25(OH)D levels (Bu et al. 
2010; Cooper et al. 2011; Engelman et al. 2013; Lu et al. 
2012; Zhang et al. 2012). On the other hand, in AAs, stud-
ies have shown that genetic ancestry contributes to serum 
25(OH)D variation (Signorello et al. 2010; Yao et al. 2012), 
but the association of the GWAS-identified SNPs with 
serum 25(OH)D levels has not been fully explored. Only 
a few GWAS-identified variants, located in GC, show sig-
nificant association with serum 25(OH)D levels in AAs 
(Engelman et al. 2008; Powe et al. 2013; Signorello et al. 
2011). Here, we investigated if 39 SNPs in eight vitamin D 
pathway genes were associated with serum 25(OH)D con-
centrations in AAs and EAs.
Materials and methods
Subjects
A total of 652 AA men (226 AAs from Washington, D.C. 
and 426 AAs from Chicago) and 405 EA men from Chi-
cago were included for this study. The subjects from Wash-
ington, D.C. were recruited at Howard University Hospital 
(Bonilla et al. 2011; Robbins et al. 2011). The participants 
from Chicago were recruited at University of Illinois Hos-
pital and Health Sciences System, Northwestern Memorial 
Hospital, Cook County Health and Hospital System, Jesse 
Brown Veterans Affairs Medical Center, and University 
of Chicago Hospital (Murphy et al. 2012). All of the par-
ticipants were unrelated and self-identified as AA or EA. 
Individuals with liver and/or chronic kidney disease were 
excluded from the analyses.
Blood samples for 25(OH)D assays and DNA analy-
sis, demographic information, and information on poten-
tial modifiers of serum 25(OH)D were collected at the 
time of recruitment. Research coordinators conducted 
in-person interviews, administered structured question-
naires, and obtained information on ancestry, medical his-
tory, income, education, marital status, and lifetime history 
of sun exposure (Murphy et al. 2012). Skin color of upper 
inner arm was measured using a portable narrow-band 
reflectometer, called DermaSpectrometer (Cyberderm, 
PA) (Shriver and Parra 2000; Shriver et al. 2003). Dietary 
vitamin D intake was assessed using a Block calcium and 
vitamin D screener validated for use in the AA popula-
tion (Block et al. 1990; Coates et al. 1991). UVR exposure 
was assessed using a questionnaire that evaluates outdoor 
activities and geographic residence. The serum samples 
were stored at −20 °C until 25(OH)D measurement. Total 
25(OH)D concentration was assessed using the Diasorin® 
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chemiluminescence immunoassay method in the Depart-
ment of Pathology NorthShore University HealthSystem. 
We defined vitamin D deficiency as serum 25(OH)D lev-
els <50 nmol/l (<20 ng/ml) and vitamin D insufficiency as 
25(OH)D levels between 50 and 75 nmol/l (20 and 30 ng/
ml) (Holick 2007; Holick et al. 2011).
Genetic analysis
We genotyped 39 SNPs in eight vitamin D metabolic 
pathway genes (GC, DHCR7/NADSYN1, VDR, CYP2R1, 
CYP27A1, CYP27B1, CYP3A4, and CYP24A1), includ-
ing 19 GWAS-identified variants (Table 1; Supplementary 
Table 1) (Ahn et al. 2010; Wang et al. 2010). SNP selection 
process was previously described in Pibiri et al. (2014). 
Individual genetic ancestry was determined for each per-
son using 105 autosomal DNA ancestry informative mark-
ers (AIMs) for West African, Native American, and Euro-
pean genetic ancestry using published methods (Giri et al. 
2009; Tian et al. 2006). All the genotyping was performed 
using iPLEX Sequenome MassARRAY. All the individuals 
included in the study had genotyping calling rate of >95 %.
Statistical analysis
Allelic association tests were performed using linear 
regression models to investigate the association with log-
transformed serum 25(OH)D levels and logistic regression 
models to test the association with vitamin D deficiency 
(<50 nmol/l). We performed separate analyses for AAs 
and EAs because of differences in linkage disequilibrium 
(LD), allele frequencies, and biological and environmental 
factors contributing to serum 25(OH)D levels in the two 
populations. For the analyses of AAs, we adjusted for age, 
West African ancestry (WAA), and study site (Model 1, 
n = 652). We also tested for association adjusting for age, 
WAA, study site, and environmental predictors (Model 2, 
n = 557). We adjusted for WAA to control for population 
stratification in the admixed AA populations. For the analy-
ses of EAs, we adjusted for age (Model 1, n = 405), and 
we performed analyses further adjusting for environmental 
predictors (Model 2, n = 385). We treated total vitamin D 
intake, season of blood draw, and UVR exposure as binary 
variables. We treated total vitamin D intake as a binary var-
iable (<400 IU/day vs. ≥400 IU/day, Institute of Medicine 
Estimated Average Requirement), because it was not nor-
mally distributed. We defined from June to November as 
UVR high months and from December to May as low UVR 
months to account for serum 25(OH)D decay time. Mean 
serum 25(OH)D levels were not different between individ-
uals with UVR medium and low exposure, so the levels of 
UVR exposure were categorized into high vs. low/medium 
exposure. For GWAS-identified SNPs, we considered the 
P < 0.05 as the threshold for statistical significance. For 
other SNPs, pointwise empirical P values and empirical P 
values corrected for multiple testing were obtained using 
the max(T) permutation procedure (10,000 permutations) 
using PLINK (Purcell et al. 2007). Additional statistical 
analyses were conducted using IBM SPSS Statistics, ver-
sion 21.0 (IBM Corp., Armonk, NY). We derived a Genetic 
Risk Score for vitamin D deficiency by adding the number 
of risk alleles of the top two most significantly associated 
SNPs in AAs and EAs. Power analysis was performed 
using SPSS SamplePower (IBM Corp., Armonk, NY).
Genetic ancestry was estimated using STRUCTURE 
software from the AIMs genotyped (Falush et al. 2003; 
Pritchard et al. 2000). We ran STRUCTURE under the 
admixture model using prior population information and 
independent allele frequencies with Markov Chain Monte 
Carlo (MCMC) method using K = 3 parental populations 
(West African, European, and Native American) and a burn-
in length of 30,000 for 70,000 repetitions. Each partici-
pant was scored from 0 to 100 % for individual estimates 
of West African, Native American and European ancestry. 
Mean WAA in AAs was 0.79, which was similar to previ-
ous estimates in the study populations (Batai et al. 2012). 
LD patterns were examined using HaploView (Barrett et al. 
2005). Synthesis-View was used to visualize the results of 
SNP associations in linear regression models (Pendergrass 
et al. 2010).
Table 1  Vitamin D pathway genes investigated
Chromosome Gene Number of SNPs Full name of gene
2 CYP27A1 1 Cytochrome P450, family 27, subfamily A, polypeptide 1
4 GC 9 Vitamin D binding protein
7 CYP3A4 1 Cytochrome P450, family 3, subfamily A, polypeptide 4
11 CYP2R1 5 Cytochrome P450, family 2, subfamily R, polypeptide 1
DHCR7/NADSYN1 8 7-Dehydrocholesterol reductase/NAD synthetase 1
12 VDR 7 Vitamin D receptor
CYP27B1 2 Cytochrome P450, family 27, subfamily B, polypeptide 1
20 CYP24A1 6 Cytochrome P450, family 24, subfamily A, polypeptide 1
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Results
Vitamin D deficiency and insufficiency were more com-
mon in AAs than in EAs (Table 2; Supplementary Fig. 1). 
The majority of our AA study participants (85.8 %) were 
vitamin D insufficient or deficient with 25(OH)D levels 
<75 nmol/l. Although many of them were recruited in the 
high UV months, more than half of them (57.5 %) were 
vitamin D deficient with 25(OH)D levels <50 nmol/l. Mean 
serum 25(OH)D levels was significantly higher in EAs than 
in AAs, and only 28.9 % of EA study participants were 
vitamin D deficient. Total vitamin D intake was lower in 
AAs than in EAs, and significantly higher proportion of 
EAs had total vitamin D intake ≥400 IU/day (P < 0.001). A 
much smaller proportion of AAs (14.9 %) had the Institute 
of Medicine Recommended Dietary Allowance (≥600 IU/
day) compared to EAs (25.4 %).
Before we tested SNP associations, we performed mul-
tiple linear regression analyses to identify biological and 
environmental modifiers of serum 25(OH)D concentrations 
(Supplementary Table 2). Among AAs, study site, total 
vitamin D intake and season of blood draw were signifi-
cantly associated with serum 25(OH)D levels (P < 0.001). 
Skin pigmentation and WAA were not associated with 
serum 25(OH)D levels. In EAs, age (P = 0.006), season of 
blood draw (P < 0.001), total vitamin D intake (P < 0.001), 
and body mass index (BMI) (P < 0.001) were significantly 
associated with serum 25(OH)D levels. Also, UVR expo-
sure was marginally associated with serum 25(OH)D lev-
els (P = 0.06) in EAs. These significant modifiers of serum 
25(OH)D levels were included in the linear and logistic 
regression models in our genetic association analyses.
Of the 39 SNPs genotyped, two SNPs in VDR, 
rs2228570 (FokI) and rs1989969, were hypervariable 
loci exhibiting more than two alleles, and we removed 
them from our analyses. We also excluded rs11568820 
(Cdx2) from the analyses in AAs, because it deviated from 
Hardy–Weinberg Equilibrium (P < 0.001). A CYP27A1 
SNP, rs116071925, was excluded in the analyses of EAs, 
because it was monomorphic.
In the linear regression models among AAs, we observed 
stronger associations of SNPs with serum 25(OH)D lev-
els when we additionally adjusted for vitamin D intake 
and season of blood draw (Model 2) than when only age, 
WAA, and study site were included (Model 1). In Model 
1, three GWAS-identified SNPs (1 in CYP2R1 and 2 in 
DHCR7/NADSYN1) were significantly associated with 
serum 25(OH)D levels (Supplementary Table 3). Although 
the number of individuals included was smaller in Model 
2 than in Model 1, five GWAS-identified SNPs (1 in GC 
and 4 in CYP2R1) and one non-GWAS-identified SNP in 
GC were significantly associated with serum 25(OH)D 
levels in Model 2 (Fig. 1; Table 3). Two CYP2R1 SNPs, 
rs12794714 and rs10741657, equally showed strong asso-
ciation (P = 0.01). These two SNPs were weakly linked 
(r2 = 0.07) (Supplementary Fig. 2). When these two SNPs 
were included in the regression model, they showed inde-
pendent association (P = 0.04 for both rs10741657 and 
rs12794714). The logistic regression analysis for vitamin 
D deficiency supports the strong associations of CYP2R1 
SNPs, and rs12794714 showed the strongest associa-
tion with vitamin D deficiency (P = 0.003, OR = 1.72, 
95 % C.I.; 1.20–2.47). A previously reported GC SNP, 
rs115563, was weakly associated with serum 25(OH)D 
levels (P = 0.048). Although not significant after correct-
ing for multiple testing, another SNP in GC, rs115316390, 
that was not reported in the GWAS meta-analyses showed 
stronger association with serum 25(OH)D levels. This SNP 
was not in LD with rs1155563 (r2 < 0.001), and they were 
independently associated (P = 0.03 for both rs1155563 
and rs115316390), when they were adjusted for each 
other in the regression model. Although the two SNPs in 
DHCR7/NADSYN1 were not associated with 25OHD in 
Model 2 in the linear regression analysis, rs12800438 
Table 2  Study participants’ characteristics
a
 P values were calculated from independent sample T test for continuous variables and χ2 test for categorical variables
b
 Vitamin D severe deficient (<25.0 nmol/l), deficient (25.0–49.9 nmol/l), insufficient (50.0–74.9 nmol/l), and sufficient (≥75.0 nmol/l)
African Americans (n = 652) European Americans (n = 405) P valuesa
Age, mean (SD) 59.0 (10.0) 60.9 (8.4) 0.001
25(OH)D (nmol/l), mean (SD) 47.8 (24.2) 64.9 (28.2) <0.001
Vitamin D statusb, % <0.001
 Severe deficient 14.1 4.2
 Deficient 43.4 24.7
 Insufficient 28.3 38.8
 Sufficient 13.2 32.4
UV high season, from June to November, % 62.1 39.0 <0.001
Total vitamin D intake ≥ 400 IU/day,  % 36.4 49.7 <0.001
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Fig. 1  −log10 P value from linear regression analysis (Model 2) in 
African Americans (Blue) and European Americans (Red). Additive 
effect of minor allele was tested, and the triangles indicate direction 
of effect (β). The horizontal line shows the statistical significance 
threshold at α = 0.05
Table 3  SNPs associated with serum 25(OH)D levels in African Americans and European Americans
Statistically significant P values at α = 0.05 are bolded
a
 Adjusted for age, WAA, study site, total vitamin D intake, and season of blood draw (Model 2)
b
 Adjusted for age, total vitamin D intake, season of blood draw, BMI, and UVR exposure (Model 2)
c




 Empirical P values obtained using max(T) permutation procedure (10,000 permutations) correcting for multiple testing. Permutation test was 
not performed for GWAS-identified SNPs
Chromosome Gene SNPs Position African Americansa European Americansb
(BP)c MAd β P values PeEMP MAd β P values PeEMP
4 GC rs17467825 72605517 G −0.01 0.62 G −0.04 0.003
rs2282679 72608383 C −0.01 0.68 C −0.05 0.001
rs3755967 72609398 A −0.02 0.30 A −0.04 0.002
rs2298850 72614267 G −0.01 0.65 G −0.03 0.04
rs7041 72618334 G 0.01 0.57 T −0.04 0.0007
rs1155563 72643488 C −0.04 0.048 C −0.02 0.31
rs115316390 72651159 A 0.17 0.03 0.33 A 0.07 0.44 1.00
11 CYP2R1 rs1993116 14910234 T 0.03 0.02 T 0.04 0.0006
rs12794714 14913575 A −0.04 0.01 A −0.04 0.005
rs10741657 14914878 A 0.04 0.01 A 0.04 0.003
rs2060793 14915310 A 0.03 0.02 A 0.04 0.005
20 CYP24A1 rs73913757 52790518 T 0.00 0.99 1.00 T −0.09 0.04 0.49
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was significantly associated with vitamin D deficiency 
(P = 0.04, OR = 0.76, 95 % C.I.; 0.58–0.99) in AAs.
A contrasting pattern of associations was observed 
in EAs. Compared to AAs, there were more SNPs with 
stronger signal of association in both Models (Fig. 1; 
Supplementary Table 4), and different SNPs from those 
found in AAs showed stronger association. Nine GWAS-
identified SNPs were significantly associated with serum 
25(OH)D concentrations. A CYP2R1 SNP, rs1993116, 
showed the strongest evidence of association (P = 0.0006). 
After adjusting for rs1993116, no other SNP in CYP2R1 
remained significant. The logistic regression analysis con-
firmed the strongest association of this SNP (P = 0.0008, 
OR = 0.51, 95 % C.I.; 0.35–0.76). A GC SNP, rs7041, 
showed the second strongest association (P = 0.0007), and 
after conditioning on this SNP in the regression analyses, 
other GC SNPs were no longer significantly associated 
with serum 25(OH)D levels. Figure 1 shows the different 
directions of association (β) in AAs and EAs for rs7041. 
However, different alleles were tested in AAs and EAs, 
because the minor allele in AAs was the major allele in 
EAs, and rs7041 was not associated with serum vitamin D 
levels in AAs. In addition, a CYP24A1 SNP, rs73913757, 
was associated with serum 25(OH)D levels (P = 0.04), but 
it was not significant after controlling for multiple testing.
To understand the additive effects of the significant vita-
min D pathway gene variants on serum 25(OH)D levels, 
we performed linear regression analysis by adding the top 
two independently associated SNPs to the linear regres-
sion model with the biological and environmental modi-
fiers. In AAs, the model including age, WAA, study site, 
total vitamin D intake, and season of blood draw explained 
19.1 % of the variance in serum 25(OH)D levels (adjusted 
R2 = 0.191). We added a CYP2R1 SNP, rs12794714, 
that showed the strongest association in single SNP lin-
ear regression and logistic regression analysis, and a GC 
SNP, rs115316390, to the linear regression model. The 
two SNPs together explained an additional 1.1 % of the 
serum 25(OH)D variation (adjusted R2 = 0.202). Genetic 
Risk Score was calculated using the top two SNPs by add-
ing the number of A alleles for rs12794714 (CYP2R1) and 
G alleles for rs115316390 (GC). The Genetic Risk Score 
ranged from one to four (Fig. 2a). As the Genetic Risk 
Score increased, proportion of vitamin D-deficient indi-
viduals increased. A small proportion (28.6 %) of AAs who 
carry one risk allele was vitamin D deficient. Vitamin D 
deficiency was very common in AAs who carry four risk 
alleles (76.0 %). In linear regression model adjusting for 
age, WAA, study site, season, and vitamin D intake, the 
Genetic Risk Score was significantly associated with serum 
25(OH)D levels (β = −0.044, P = 0.005). The regression 
coefficient (β) estimates for these two SNP were different, 
so we weighted the Genetic Risk Score using β estimates. 
In the same linear regression model, the weighted Genetic 
Risk Score was also significantly associated with serum 
25(OH)D levels (β = −0.947, P = 0.001).
Similarly, compared to biological and environmental 
modifiers, genetic variation explained a small proportion 
of serum 25(OH)D variation in EAs. SNPs and biologi-
cal and environmental modifiers, however, accounted for 
greater serum 25(OH)D variation in EAs than in AAs. 
Adjusted R2 in the linear regression model including the 
age, total vitamin D intake, season of blood draw, BMI, and 
UVR exposure was 0.241. The model including two SNPs, 
rs7041 (GC) and rs1993116 (CYP2R1) and environmen-
tal variables accounted for 28.2 % of variance (adjusted 
R2 = 0.282). Genetic Risk Score was calculated with sum 
of the number of C alleles for rs1993116 (CYP2R1) and T 













































Fig. 2  Percent vitamin D deficiency for each unweighted Genetic 
Risk Score using top two SNPs; rs12794714 (CYP2R1) and 
rs115316390 (GC) in African Americans (a), and rs1993116 
(CYP2R1) and rs7041 (GC) in European Americans (b)
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of EAs who had zero risk allele was vitamin D deficient 
(Fig. 2b). Vitamin D deficiency was less common in EAs 
than in AAS, and less than half (42.9 %) of EAs who had 
four risk alleles were vitamin D deficient. The Genetic Risk 
Score was also strongly associated with serum 25(OH)D 
levels (β = 0.043, P < 0.001) in linear regression model 
adjusting for age, BMI, season, vitamin D intake, and UV 
exposure. Because the regression coefficient was virtually 
identical for two SNPs, we did not perform analysis with 
weighted Genetic Risk Score.
Increments of R2 for rs12794714 and rs115316390, 
when they were added to the regression model (Model 2) 
in AAs, were 0.008 and 0.006, respectively. Our AA sam-
ples provide only 65 and 56 % power for these two SNPs 
to detect the effect size at a significance level of α = 0.05. 
In EAs, increments of R2 for the top two SNPs were larger. 
When rs7041 and rs1993116 were added to the regression 
models with the other modifiers, R2 increase were 0.022 
and 0.021, respectively. Our EA samples have 90 and 89 % 
power to detect the observed R2 increment.
Discussion
In this study of 652 AAs and 405 EAs, we investigated the 
association of 37 candidate SNPs in eight vitamin D path-
way gene regions, and we successfully replicated GWAS 
findings in our AA and EA populations demonstrating that 
six SNPs in three vitamin D pathway genes in AAs and 
nine SNPs in two genes in EAs were significantly associ-
ated with serum 25(OH)D levels or vitamin D deficiency 
(Supplementary Table 5). We also found a previously unre-
ported SNP in GC among AAs and a SNP in CYP24A1 
among EAs that were associated with serum 25(OH)D 
levels, though they were not significantly associated after 
correcting for multiple testing. The strength of associations 
and the SNPs that showed the strongest signal of associa-
tion were, however, different between AAs and EAs.
When human skin is exposed to UVR, 7-dehydrocho-
lesterol is converted to pre-vitamin D3 (Holick 2007). Also 
within the skin, the enzyme, 7-dehydrocholesterol reductase 
(DHCR7) catalyzes the conversion of 7-dehydrocholesterol 
to cholesterol. Thus, increased activity of DHCR7 poten-
tially lowers the bioavailability of 7-dehydrocholesterol for 
vitamin D synthesis. Two GWAS meta-analyses identified 
SNPs in DHCR7 and a nearby gene, NADSYN1, strongly 
associated with serum 25(OH)D levels in European popu-
lations (Ahn et al. 2010; Wang et al. 2010). We, however, 
failed to replicate these findings in our EA samples. In our 
AA sample, one SNP in this region was weakly associated 
with vitamin D deficiency (P = 0.04). Decreased ability to 
synthesize vitamin D due to older age and/or darker skin 
pigmentation may explain the inconsistent results between 
our study and the two GWAS meta-analyses (Armas et al. 
2007; Clemens et al. 1982; MacLaughlin and Holick 1985). 
Our study participants are older individuals living in urban 
areas at northern latitudes where high UVR is available 
for only several months of the year (Fioletov et al. 2010). 
Also, in our study participants, skin pigmentation was not 
associated with serum 25(OH)D levels. A major source of 
vitamin D among them appears to be dietary intake rather 
than UVR, and in the linear regression analysis, vitamin D 
dietary intake explained a higher proportion of serum vita-
min D variance than season of blood draw or UVR. None-
theless, this is the first study to investigate the association 
of DHCR7/NADSYN1 SNPs with serum 25(OH)D levels 
among people of African descent.
Vitamin D that is synthesized in the skin or consumed 
from the diet is converted to a circulating form of vitamin 
D, 25(OH)D, in the liver with the enzyme, hydroxylase, and 
DNA sequence variants in these hydroxylase genes, such as 
CYP2R1, may impact vitamin D metabolism. In our study, 
SNPs in CYP2R1 showed the strongest signal of associa-
tion in both AAs and EAs. The CYP2R1 SNP, rs1993116, 
was most strongly associated with serum vitamin D sta-
tus in our EA subjects and also showed the strongest sig-
nal of association within this gene in one of the GWAS 
meta-analyses (Ahn et al. 2010). However, rs12794714, 
the CYP2R1 SNP that consistently showed the strong-
est association with serum 25(OH)D levels and vitamin D 
deficiency in our AA subjects, was not the most strongly 
associated SNP in either GWAS meta-analyses. Two other 
studies investigated the association of CYP2R1 SNPs and 
serum 25(OH)D levels in AAs, but none of the associations 
were significant (Pillai et al. 2011; Signorello et al. 2011). 
The different associations observed for these two CYP2R1 
SNPs between AA and EA populations maybe due to dif-
ferences in LD across populations. While rs1993116 and 
rs1279714 were moderately linked in EAs (r2 = 0.46), the 
two SNPs show weak linkage in AAs (r2 = 0.05) (Supple-
mentary Fig. 2). The LD difference suggests that a func-
tional variant exists in the vicinity of these SNPs.
After vitamin D is converted to 25(OH)D, 25(OH)D 
binds to the vitamin D binding protein and is transported 
to target tissues through the circulation system. Sequence 
variants may reduce expression of GC or ability of vita-
min D binding protein to bind to 25(OH)D. Thus, SNPs 
within GC may reduce circulating 25(OH)D levels. The 
two GWAS meta-analyses found the strongest signal of 
association with SNPs in GC (Ahn et al. 2010; Wang et al. 
2010). In these GWAS, rs2282679 had the lowest P value, 
but other GC SNPs showed stronger associations than 
rs2282679 in our AA and EA populations. Although the 
association of rs2282679 has been consistently replicated 
in many smaller scale replication and candidate gene stud-
ies in African Americans, European Americans, and Asians, 
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these studies often find other SNPs in GC showing stronger 
association than the GWAS top hit (Bu et al. 2010; Lu et al. 
2012; Signorello et al. 2011; Zhang et al. 2012, 2013).
The SNP, rs7041, in exon 11 of GC creates an 
Asp → Glu amino acid change in the vitamin D binding 
protein. In our EA population, rs7041 showed the strong-
est association with serum 25(OH)D levels. The association 
of this SNP with 25(OH)D levels was consistently demon-
strated in the two GWAS meta-analyses (Ahn et al. 2010; 
Wang et al. 2010) and in smaller studies in European popu-
lations (Cooper et al. 2011; Engelman et al. 2013; Sinotte 
et al. 2009) as well as in AAs (Engelman et al. 2008; Powe 
et al. 2013). Along with this SNP, another missense muta-
tion at rs4588 (Thr → Lys) was associated with serum 
25(OH)D and vitamin D binding protein levels in AAs and 
other racial/ethnic groups, demonstrating the functional 
importance of these two SNPs (Carpenter et al. 2013; Powe 
et al. 2013). We note that the minor allele of rs7041 (G) in 
our AAs was the major allele in EAs, and this allele was 
positively correlated with serum 25(OH)D in our EAs, but 
not in our AA samples or in another study in AAs (Signo-
rello et al. 2011). Instead, Signorello et al. (2011) found 
the strongest association with rs2298849, which is less 
than 1 kb away from rs1155563, the SNP that was signifi-
cantly associated with 25(OH)D levels in our AAs. These 
two GC SNPs exhibited very little LD in African descent 
populations (r2 = 0.03 in YRI and r2 = 0.04 in ASW). The 
SNP, rs115316390, located in the intron region showed the 
strongest GC association in our AA population (P = 0.03). 
Although the association was not significant after correct-
ing for multiple testing, this study is the first to report the 
evidence of association of rs11531690 with serum 25(OH)
D concentrations. These data suggest that there could 
be other functional variants in the vicinity of these SNPs 
affecting serum 25(OH)D and vitamin D binding protein 
levels. It should also be noted that while serum vitamin 
D binding protein levels stay relatively stable over time, 
serum 25(OH)D levels can seasonally fluctuate (Harris and 
Dawson-Hughes 1998; Sonderman et al. 2012).
Contrasting patterns between AAs and EAs were also 
observed when significantly associated SNPs in CYP2R1 
and GC were added to our full linear regression model with 
the relevant covariates. Two SNPs, one each from CYP2R1 
and GC, together explained more of the variation in serum 
25(OH)D levels in EAs than in AAs (4.1 % increase in R2 
among EAs compared to a 1.1 % increase among AAs). 
Nevertheless, these SNPs account for a very small propor-
tion of variation in serum 25(OH)D levels in both popula-
tions compared to behavioral, biological, and environmen-
tal predictors.
Several studies have shown that an increasing Genetic 
Risk Score, or number of risk alleles, is associated with 
decreased serum 25(OH)D levels or vitamin D deficiency/
insufficiency using the candidate SNPs (Engelman et al. 
2013; Lu et al. 2012; Signorello et al. 2011; Zhang et al. 
2013). Each study used a different set of SNPs, and the 
strongest signals of association were found at different 
SNPs. There is heterogeneity in the study of SNP allele fre-
quencies and LD variation across the studied populations. 
Without knowing the causal variants, such analyses may 
provide a limited interpretive value for prevention strate-
gies or recommendations for vitamin D supplementation.
Differences in behavioral and environmental factors, 
variation in LD across different populations, and the small 
sample size of this study likely caused the inconsistencies 
observed for associations across studies. Our EA study par-
ticipants were more likely to have higher education levels 
and income, and more prevalent use of vitamin D supple-
mentation than AA study participants (Murphy et al. 2012). 
Moreover, many believe that consistently significant dif-
ferences in serum 25(OH)D levels between AAs and EAs 
even after adjusting for relevant behavioral, biological, and 
environmental variables suggest that skin pigmentation is 
one of the major contributing factors (Harris 2011; Harris 
and Dawson-Hughes 1998; Signorello et al. 2010). How-
ever, the impact of skin pigmentation differences between 
AAs and EAs on the observed difference in serum vita-
min D levels and contrasting pattern of associations is still 
not clear. In this project, we used an objective method of 
measuring skin pigmentation and skin pigmentation was 
not associated with serum vitamin D levels in AAs. Our 
AA subjects exhibited large variation in skin color and thus 
more analyses are necessary to understand the role of skin 
pigmentation on vitamin D disparities.
The limitations of this study are the low number of tag-
ging SNPs genotyped and small sample size. We selected a 
small number of tagging SNPs that are most likely in LD 
with causal variants, but the tagging SNPs selected based 
on the GWAS in European populations may not be suitable 
in AAs. Fine mapping around the region with strong sig-
nals of association in our AAs may help identify other vari-
ants that show stronger association and find functional vari-
ants that may affect vitamin D synthesis and metabolism. 
Compared to the previous GWAS meta-analyses (Ahn et al. 
2010; Wang et al. 2010), our study had small sample size. 
Despite small sample size, our EA samples size was suf-
ficient to observe the significant associations for the GWAS 
top hint in GC and CYP2R1. The genetic effect in AAs, 
on the other hand, was smaller, and we may not have had 
enough statistical power. This study, however, is the second 
largest that examined association of circulating 25(OH)D 
levels and genetic variations in AA populations. This study 
also incorporated many biological and environmental mod-
ifiers of serum 25(OH)D levels, including objective meas-
urements of skin pigmentation, into the analyses. Com-
bined effect of gene and environment likely explains the 
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difference in prevalence of vitamin D deficiency between 
AAs and EAs (Moonesinghe et al. 2012). Our future stud-
ies will explore whether gene–environment interactions 
play a role in vitamin D disparities between AAs and EAs.
Vitamin D deficiency is very common among AAs and 
is considered to be a potential contributor to health dispari-
ties. For EA adults, increasing vitamin D intake from sup-
plementation or diet to more than 600 IU/day is necessary 
to keep serum 25(OH)D levels at 50 nmol/l (20 ng/ml), but 
maintaining levels ≥75 nmol/l (30 ng/ml) likely requires 
more than 1,500 IU/day of vitamin D (Holick et al. 2011; 
Institute of Medicine 2011; Ross et al. 2011). Administer-
ing 2,000 IU/day of vitamin D supplementation is shown to 
raise serum vitamin D to sufficient levels in AA populations 
(Dong et al. 2010; Talwar et al. 2007), and 4,000 IU/day of 
vitamin D supplement intake eliminated the differences in 
serum 25(OH)D levels between AA and EA men (Garrett-
Mayer et al. 2012). These studies, however, observed a 
considerable variation in serum 25(OH)D levels, even after 
accounting for vitamin D supplement intake. Another study 
investigating the impact of vitamin D supplementation also 
observed high variation in serum 25(OH)D levels within 
each category of vitamin D supplement dose (Garland et al. 
2011). UVR exposure, skin color, season, BMI, and other 
environmental factors contribute to the variation, but bio-
logical factors and genetic variation in vitamin D pathway 
genes affecting rate of 25-hydroxylation likely play a role 
in dose response to vitamin D supplementation (McDon-
nell et al. 2013; Nimitphong et al. 2013). For instance, AA 
individuals who carry genetic variants that reduce vitamin 
D hydroxylation and binding protein stability may require 
substantially higher doses of vitamin D supplementation to 
maintain optimal serum 25(OH)D levels.
In summary, this study successfully replicated several 
GWAS-identified SNPs associated with 25(OH)D levels in 
AA and EA populations. The results also provide evidence 
that CYP2R1 and GC contribute more to serum 25(OH)D 
variation than other genes in the vitamin D pathway in our 
study populations. The contrasting pattern of associations 
between AAs and EAs suggests that additional studies are 
warranted to identify the causal variants affecting vitamin 
D binding and enzymatic activities.
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